Multicystic and Well-differentiated Papillary Peritoneal Mesothelioma Treated by Surgical Cytoreduction and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

By Baratti D.  

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2790-2797

Springer Publishing Company

Access to resources Recommend Favorite

In Reply: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must Be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma

By Baratti D.  

Annals of Surgical Oncology, Vol. 17, Iss. 6, 2010-06 ,pp. : 1713-1714

Springer Publishing Company

Access to resources Recommend Favorite

Failure Analysis of Recurrent Disease Following Complete Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer

By Bijelic Lana   Yan Tristan   Sugarbaker Paul  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2281-2288

Springer Publishing Company

Access to resources Recommend Favorite

Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin

By Blackham Aaron  

Annals of Surgical Oncology, Vol. 17, Iss. 10, 2010-10 ,pp. : 2720-2727

Springer Publishing Company

Access to resources Recommend Favorite

Toxicity and Outcomes Associated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Sarcomatosis

By Lim Sherry   Cormier Janice   Feig Barry   Mansfield Paul   Benjamin Robert   Griffin Janet   Chase Judy   Pisters Peter   Pollock Raphael   Hunt Kelly  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2309-2318

Springer Publishing Company

Access to resources Recommend Favorite